MCID: OVR018
MIFTS: 10

Ovarian Clear Cell Malignant Adenofibroma

Categories: Cancer diseases

Aliases & Classifications for Ovarian Clear Cell Malignant Adenofibroma

MalaCards integrated aliases for Ovarian Clear Cell Malignant Adenofibroma:

Name: Ovarian Clear Cell Malignant Adenofibroma 12
Ovarian Clear Cell Adenocarcinofibroma 12 69

Classifications:



External Ids:

Disease Ontology 12 DOID:6554
NCIt 46 C40079
UMLS 69 C2075522

Summaries for Ovarian Clear Cell Malignant Adenofibroma

MalaCards based summary : Ovarian Clear Cell Malignant Adenofibroma, is also known as ovarian clear cell adenocarcinofibroma. The drugs Paclitaxel and Carboplatin have been mentioned in the context of this disorder. Affiliated tissues include endothelial.

Related Diseases for Ovarian Clear Cell Malignant Adenofibroma

Diseases in the Ovarian Clear Cell Adenofibroma family:

Ovarian Clear Cell Malignant Adenofibroma

Symptoms & Phenotypes for Ovarian Clear Cell Malignant Adenofibroma

Drugs & Therapeutics for Ovarian Clear Cell Malignant Adenofibroma

Drugs for Ovarian Clear Cell Malignant Adenofibroma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 20)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Paclitaxel Approved, Vet_approved Phase 3 33069-62-4 36314
2
Carboplatin Approved Phase 3 41575-94-4 10339178 38904 498142
3
Gemcitabine Approved Phase 3 95058-81-4 60750
4
Bevacizumab Approved, Investigational Phase 3 216974-75-3
5
Docetaxel Approved May 1996, Investigational Phase 3 114977-28-5 148124 9877265
6 Mitogens Phase 3
7 Albumin-Bound Paclitaxel Phase 3
8 Angiogenesis Inhibitors Phase 3
9 Angiogenesis Modulating Agents Phase 3
10 Antibodies, Monoclonal Phase 3
11 Endothelial Growth Factors Phase 3
12 Anti-Infective Agents Phase 3
13 Immunoglobulins Phase 3
14 Immunosuppressive Agents Phase 3
15 Antimetabolites Phase 3
16 Antimetabolites, Antineoplastic Phase 3
17 Antimitotic Agents Phase 3
18 Antibodies Phase 3
19 Antineoplastic Agents, Phytogenic Phase 3
20 Antiviral Agents Phase 3

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer Active, not recruiting NCT01167712 Phase 3 Carboplatin;Paclitaxel
2 Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Active, not recruiting NCT00565851 Phase 3 Carboplatin;Docetaxel;Gemcitabine Hydrochloride;Paclitaxel

Search NIH Clinical Center for Ovarian Clear Cell Malignant Adenofibroma

Genetic Tests for Ovarian Clear Cell Malignant Adenofibroma

Anatomical Context for Ovarian Clear Cell Malignant Adenofibroma

MalaCards organs/tissues related to Ovarian Clear Cell Malignant Adenofibroma:

38
Endothelial

Publications for Ovarian Clear Cell Malignant Adenofibroma

Variations for Ovarian Clear Cell Malignant Adenofibroma

Expression for Ovarian Clear Cell Malignant Adenofibroma

Search GEO for disease gene expression data for Ovarian Clear Cell Malignant Adenofibroma.

Pathways for Ovarian Clear Cell Malignant Adenofibroma

GO Terms for Ovarian Clear Cell Malignant Adenofibroma

Sources for Ovarian Clear Cell Malignant Adenofibroma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....